134 related articles for article (PubMed ID: 11267610)
1. Effect of cyclosporine withdrawal on IL-10 production in kidney transplant recipients.
Alberú J; Richaud-Patin Y; Mancilla E; Díliz H; Correa-Rotter R; Chew-Wong A; Uribe N; de Leo C; Llorente L
Transplant Proc; 2001; 33(1-2):2024-7. PubMed ID: 11267610
[No Abstract] [Full Text] [Related]
2. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients.
Hricik DE; Seliga RM; Fleming-Brooks S; Bartucci MR; Schulak JA
Clin Transplant; 1995 Oct; 9(5):419-23. PubMed ID: 8541637
[TBL] [Abstract][Full Text] [Related]
3. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
[No Abstract] [Full Text] [Related]
4. A randomized trial comparing cyclosporine and steroids with cyclosporine, azathioprine, and steroids in cadaveric renal transplantation.
Amenábar JJ; Gómez-Ullate P; García-López FJ; Aurrecoechea B; García-Erauzkin G; Lampreabe I
Transplantation; 1998 Mar; 65(5):653-61. PubMed ID: 9521199
[TBL] [Abstract][Full Text] [Related]
5. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
Keitel E; Bittar AE; Losekann A; Deboni L; Ceretta F; Goldani JC; Garcia VD
Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
[No Abstract] [Full Text] [Related]
6. Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.
Gotti E; Perico N; Perna A; Gaspari F; Cattaneo D; Caruso R; Ferrari S; Stucchi N; Marchetti G; Abbate M; Remuzzi G
J Am Soc Nephrol; 2003 Mar; 14(3):755-66. PubMed ID: 12595513
[TBL] [Abstract][Full Text] [Related]
7. The practical problems of prednisone in pediatric renal transplantation.
Ettenger R
Transplant Proc; 2001; 33(1-2):989-91. PubMed ID: 11267159
[No Abstract] [Full Text] [Related]
8. Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation.
Busque S; Shoker A; Landsberg D; McAlister V; Halloran P; Shapiro J; Peets J; Schulz M
Transplant Proc; 2001; 33(1-2):1266-7. PubMed ID: 11267285
[No Abstract] [Full Text] [Related]
9. Defining the risk of elective cyclosporine withdrawal in stable kidney transplant recipients.
Anjum S; Andany MA; McClean JC; Danielson B; Kasiske BL
Am J Transplant; 2002 Feb; 2(2):179-85. PubMed ID: 12099521
[TBL] [Abstract][Full Text] [Related]
10. [Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation].
Matl I; Lácha J; Lodererová A; Símová M; Teplan V; Lánská V; Vítko S
Cas Lek Cesk; 2000 Mar; 139(4):115-9. PubMed ID: 10838741
[TBL] [Abstract][Full Text] [Related]
11. A single-center open label randomized trial of the safety and efficacy of the use of sirolimus versus azathioprine in one-haplotype living related kidney transplant recipients-preliminary results.
Machado PG; Garcia C; Felipe CR; Garcia R; Franco M; Delcelo R; Silva HT; Medina JO
Transplant Proc; 2001; 33(1-2):1074-5. PubMed ID: 11267196
[No Abstract] [Full Text] [Related]
12. Steroid withdrawal in renal transplant recipients.
Ponticelli C; Tarantino A; Montagnino G
Transplant Proc; 2001; 33(1-2):987-8. PubMed ID: 11267158
[No Abstract] [Full Text] [Related]
13. A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.
Thervet E; Morelon E; Ducloux D; Bererhi L; Noël LH; Janin A; Bedrossian J; Puget S; Chalopin JM; Mihatsch M; Legendre C; Kreis H
Transplant Proc; 2000 Dec; 32(8):2778. PubMed ID: 11134800
[No Abstract] [Full Text] [Related]
14. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
[TBL] [Abstract][Full Text] [Related]
15. Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression.
Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimaräes S
Transplant Proc; 2000 Dec; 32(8):2636-8. PubMed ID: 11134735
[No Abstract] [Full Text] [Related]
16. A randomised, prospective study on the conversion from cyclosporine-prednisone to cyclosporine-azathioprine at 6 months after renal transplantation.
de Sévaux RG; Hilbrands LB; Tiggeler RG; Koene RA; Hoitsma AJ
Transpl Int; 1998; 11 Suppl 1():S322-4. PubMed ID: 9665006
[TBL] [Abstract][Full Text] [Related]
17. Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience.
Santos SM; Carlos CM; Cabanayan-Casasola CB; Danguilan RA
Transplant Proc; 2012 Jan; 44(1):154-60. PubMed ID: 22310603
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
Gracida C; Melchor JL; Miranda ME; Bartolano C
Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
[No Abstract] [Full Text] [Related]
19. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Goldfarb DA
J Urol; 2005 Jun; 173(6):2106-7. PubMed ID: 15879857
[No Abstract] [Full Text] [Related]
20. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.
Ahsan N; Hricik D; Matas A; Rose S; Tomlanovich S; Wilkinson A; Ewell M; McIntosh M; Stablein D; Hodge E
Transplantation; 1999 Dec; 68(12):1865-74. PubMed ID: 10628766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
